መነሻ › ፎካል ሴግመንታል ግሎሜሩሎስክሌሮሲስ › ካሊፎርኒያ
በካሊፎርኒያ ለፎካል ሴግመንታል ግሎሜሩሎስክሌሮሲስ የሚደረጉ ክሊኒካዊ ጥናቶች
ለፎካል ሴግመንታል ግሎሜሩሎስክሌሮሲስ የሚደረጉ 8 ጥናቶች በካሊፎርኒያ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በካሊፎርኒያ ውስጥ ያሉ ከተሞች
Official study text (English)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #2, Chula Vista
- Investigator Site #28, Garden Grove
- Investigator Site #14, Los Angeles
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- West Coast Kidney Institute, Fremont
- Kidney Disease Medical Group, Glendale
- Valiance Clinical Research, Huntington Park
- እና 8 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- University of California Irvine Medical Center- Site Number : 8400015, Orange
- University of California San Francisco - Parnassus Heights- Site Number : 8400012, San Francisco
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ16 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT06500702Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- Loma Linda University Children's Hospital, Loma Linda
- Loma Linda University Hospital, Loma Linda
ተሳታዮችን በመፈለግ ላይ
እስከ እድሜ 75 · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT04065438Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- Loma Linda University Children's Hospital, Loma Linda
- Cedars Sinai Medical Center, Los Angeles
ተሳታዮችን በመፈለግ ላይ
እስከ እድሜ 21 · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT02235857Nephrotic Syndrome Study Network
- University of Southern California-Children's Hospital, Los Angeles
- Stanford University School of Medicine, Palo Alto
- University of California San Francisco Benioff Children's Hospitals, San Francisco
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እስከ እድሜ 80 · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Cedars-Sinai Medical Center, Los Angeles
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ1 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ12 ሜይ 2026 · NCT05003986A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
- Kaiser Permanente, Oakland
- እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ12 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ3 ፌብሩ 2026 · NCT05183646ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።